NEW YORK, March 15 (GenomeWeb News) - Harvard Bioscience said yesterday that President David Green has established a stock-trading plan that will enable him to sell up to 894,963 shares of common stock over the next three years.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.